Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
This funding opportunity supports U.S.-based small businesses in developing innovative clinical diagnostic tools that address health disparities and improve healthcare access for diverse populations.
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications from Small Business Concerns (SBCs) to pursue the development of improved clinical diagnostics or the development of alternative clinical diagnostics that address health disparities created by clinical laboratory assays and/or point-of-care devices that fail to incorporate diverse patient groups. Applicants will identify a potential issue within a clinical diagnostic or group of clinical diagnostics that perpetuates health inequity and disparities, clearly define the disparity issue, and develop a solution to address the concern.